Xu, K.; Ding, J.; Zhou, L.; Li, D.; Luo, J.; Wang, W.; Shang, M.; Lin, B.; Zhou, L.; Zheng, S.
SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis. Cells 2023, 12, 25.
https://doi.org/10.3390/cells12010025
AMA Style
Xu K, Ding J, Zhou L, Li D, Luo J, Wang W, Shang M, Lin B, Zhou L, Zheng S.
SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis. Cells. 2023; 12(1):25.
https://doi.org/10.3390/cells12010025
Chicago/Turabian Style
Xu, Kangdi, Jun Ding, Lingfeng Zhou, Dazhi Li, Jia Luo, Wenchao Wang, Mingge Shang, Bingyi Lin, Lin Zhou, and Shusen Zheng.
2023. "SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis" Cells 12, no. 1: 25.
https://doi.org/10.3390/cells12010025
APA Style
Xu, K., Ding, J., Zhou, L., Li, D., Luo, J., Wang, W., Shang, M., Lin, B., Zhou, L., & Zheng, S.
(2023). SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis. Cells, 12(1), 25.
https://doi.org/10.3390/cells12010025